Bio-Sourcing
Bio-Sourcing has developed a unique, sustainable and profitable platform for the production of a new generation of biotherapeutics, in particular monoclonal antibodies.
Bio-Sourcing has raised €13M across 1 funding round from 1 investor, most recently a Grant round in Sep 2024. Based in Brussels, Belgium; active in Healthtech. Data as of 28 Oct 2026.
Brussels, Belgiumwww.bio-sourcing.com ↗
Total raised
€13M
€12,500,000
Funding rounds
1
Investors
1
distinct backers
Active since
2024-09
latest 2024-09
Funding by year
EUR raised per yearBio-Sourcing — funding by year — interactive chart.
Data table
| Bio-Sourcing — funding by year | |
|---|---|
| 2024 | €13M |
Signals
High confidenceRaise-next likelihood8
base rate 45% for Grant
- ▼ Past typical raise window
- ▼ Low backer re-investment
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-09-24 | Grant | €13M | European Innovation Council (EIC) Accelerator Programme | View deal → |
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Imec€2.5BBelgium · Deeptech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Kpler€1.0BBelgium · Software
Global coverage: FundingData